Alnylam Pharmaceuticals
ALNY
#445
Rank
S$68.10 B
Marketcap
S$515.49
Share price
-1.73%
Change (1 day)
56.99%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company